FDA Peptide Reclassification 2026: What It Means for Providers GOP lawmakers ask RFK Jr. to make FDA unleash risky peptides like BPC 157 The Niche The Food and Drug Administration will hold a meeting this summer to consider easing restrictions on more than a half dozen peptide injections, a group of unapproved therapies that have become popular FDA Compliance for Peptide Therapy and BPC 157 Holt Law Regeneration or Risk? A Narrative Review of BPC 157 for Musculoskeletal Healing Current Reviews in Musculoskeletal Medicine Springer Nature Link